98%
921
2 minutes
20
The Advisory Committee on Immunization Practices (ACIP) advised vaccinating children, adolescents and young adults against Human Papillomavirus (HPV) in 2006, aiming to prevent HPV-related cancers and genital warts. As HPV vaccination rates remained low even 10 years after it was introduced, understanding vaccination patterns is essential for informing targeted public health interventions. This study explores the demographic disparities (age, gender, race and ethnicity), temporal trends, and geographical patterns of HPV vaccine administration by analyzing large-scale immunization registry data for Long Island (LI) (Nassau and Suffolk Counties), New York (NY). The vaccine registration data retrieved from the New York State Immunization Information System (NYSIIS) was used to assess the HPV vaccine administration rate from 2012 to 2023. Patients' demographic information and regional variations were evaluated to identify the disparities between different subgroups. The HPV vaccination rate among LI children ages 9 to 13 demonstrates a growth of 284.43% from 2012 to 2019 and a slight decrease of 5.04% around 2020. Around 68.07% of individuals received their first dose before their 15 birthday and 24.95% of them received their second dose timely, given 6 to 12 months after the first dose. Spatially, eastern LI consistently holds a higher HPV vaccination rate than northwestern LI due to regional disparities. The rising trend in HPV vaccination coverage on LI with a modest drop around 2020 indicates the likely impact of COVID-19 pandemic. This study suggests the need for increased focus on regions with lower vaccine uptake rates for preventing HPV-related cancers.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12005404 | PMC |
http://dx.doi.org/10.1080/21645515.2025.2487383 | DOI Listing |
Sex Transm Dis
September 2025
University of Illinois at Chicago School of Public Health, 1603 W. Taylor St., Chicago, IL, 60612.
Background: Human papillomavirus (HPV) is a leading cause of six cancers. Despite effective vaccines, HPV vaccination rates remain suboptimal, standing at 26% of females and 9% of males, nationally in 2018. This study assessed factors associated with HPV vaccination uptake among patients at Chicago Department of Public Health (CDPH) STI Specialty Clinics.
View Article and Find Full Text PDFInt J Cancer
September 2025
Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Quebec, Canada.
In Canada, the incidence of human papillomavirus (HPV)-related head and neck cancer (HNC) is increasing. The role of multiple oral HPV infections in HNC etiology remains unclear, and evidence of HPV vaccination's effectiveness in reducing HNC incidence is limited. We investigated oral HPV co-infection patterns, estimated the association between multiple oral HPV infections and HNC risk, and the effect of eliminating vaccine-targeted HPV genotypes on HNC incidence.
View Article and Find Full Text PDFHum Vaccin Immunother
December 2025
Department of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, China.
Human papillomavirus (HPV) causes multiple diseases in both sexes. This study evaluates the cost-effectiveness and epidemiological impact - defined as reductions in HPV-related disease cases - of a gender-neutral vaccination (GNV) strategy in China's economically developed metropolises: Beijing, Shanghai, and Guangzhou. A discrete-time Markov model simulated no vaccination, female-only vaccination (FOV), and GNV strategies among 12-year-olds.
View Article and Find Full Text PDFJ Infect Dev Ctries
August 2025
Scientific Research Centre for Public Health, University of Vlore "Ismail Qemali", Vlore, Albania.
Introduction: Despite the HPV vaccine's efficacy in cervical cancer prevention, cervical cancer ranks second in prevalence among women, following breast cancer. Various factors negatively impact HPV vaccination uptake, with parents' knowledge and attitudes being particularly crucial in this regard.
Methodology: A cross-sectional study was conducted between February and May 2023, targeting parents in northern Albania.
PLoS One
September 2025
Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Background: Head and neck cancer (HNC) is a significant global health concern with rising incidence and mortality in certain regions. This study aimed to evaluate the global burden and temporal trends of HNC from 1990 to 2021 and to project its future burden through 2030.
Methods: Data were obtained from the Global Burden of Disease (GBD) 2021 study.